Dr Samuel Whittle
School of Medicine
College of Health
| Year | Citation |
|---|---|
| 2025 | Yiu, Z. Z. N., McFarlane, E., & Whittle, S. L. (2025). ‘Live long and prosper’: living guidelines for immune-mediated inflammatory diseases. Rheumatology, 64(1), 6-8. |
| 2025 | Chin, A., Terrett, A., Kwon, M., Whittle, S., & Hill, C. (2025). Recommendations for the Use of Disease-Modifying Antirheumatic Drugs in Pregnancy and Reproductive Health for Patients With Rheumatic Disease: A Scoping Review. Arthritis Care and Research, 77(10), 1273-1281. |
| 2025 | Bryant, M. J., Lester, S., Russell, O., Whittle, S., Limaye, V., Proudman, S., . . . Hill, C. L. (2025). Implementation of a novel patient reported experience measure (PREM) in rheumatology: a cross-sectional online survey of Australian rheumatology outpatients. Rheumatology International, 45(6), 10 pages. Scopus1 WoS1 Europe PMC1 |
| 2025 | St Pierre, K., Cashmore, B., Cumpston, M. S., Hill, K., McDonald, S., Pattuwage, L., . . . Tunnicliffe, D. J. (2025). Methods for living guidelines: Paper 6: Insights from ALEC’s use of existing systematic reviews in living guideline development. Journal of Clinical Epidemiology, 187, 111812-1-111812-13. Scopus2 WoS1 |
| 2025 | Sukkar, M. B., Ainley, R., Barrett, C., Bond, S., Bradbury, L. A., Briggs, A. M., . . . Hill, C. L. (2025). Development of the Australian Rheumatology Association Clinical Care Standard for the diagnosis and management of rheumatoid arthritis in adults. Journal of Rheumatology, 52(9), 883-892. |
| 2025 | Terrett, A. M., Damodaran, A., Burnet, S., Singh-Grewal, D., Buchbinder, R., Glover, J., . . . Hill, C. L. (2025). The rheumatology workforce in Australia: current and projected shortfalls. Internal Medicine Journal, 55(9), 1500-1507. |
| 2025 | White, H., Synnot, A., Glennon, V., Hill, K., Whittle, S., Seid, A., & Turner, T. (2025). Living recommendations do not “flip-flop”: examining the probability of directional changes to recommendations in living guidelines. Journal of Clinical Epidemiology, 185, 8 pages. Scopus3 WoS4 Europe PMC2 |
| 2025 | Terrett, A., Chin, A., Kwon, M., Whittle, S., & Hill, C. (2025). Perioperative management with DMARDs in rheumatic diseases: a scoping review of clinical guidelines. BMC Rheumatology, 9(1), 10 pages. Scopus1 WoS1 Europe PMC1 |
| 2025 | Pisaniello, H. L., Whittle, S. L., Johnston, R. V., Glennon, V., Grobler, L., Cyril, S., . . . Buchbinder, R. (2025). Dose reduction and discontinuation of conventional synthetic disease-modifying anti-rheumatic drugs (DMARDs) for people with rheumatoid arthritis or psoriatic arthritis in remission or low disease activity. Cochrane Database of Systematic Reviews, 9(9), CD015900. |
| 2025 | Kamso, M. M., Whittle, S. L., Pardo, J. P., Buchbinder, R., Wells, G., Deardon, R., . . . Hazlewood, G. S. (2025). A semi-automated approach facilitated the assessment of the certainty of evidence in a network meta-analysis: Part 1 - Direct comparisons.. Journal of clinical epidemiology, 112109. |
| 2025 | Saadat, P., Bansback, N., Falahee, M., Hiligsmann, M., Tugwell, P., Buchbinder, R., . . . Hazlewood, G. (2025). Patient preferences for drug therapy in inflammatory arthritis: protocol for a living systematic review and evidence map to inform clinical practice guidelines. BMJ Open, 15(1), e088267-1-e088267-7. Scopus1 WoS1 Europe PMC1 |
| 2025 | Synnot, A., Chakraborty, S., Xue, J., Cheng, H. Z., Berkovic, D., Turner, T., . . . Glennon, V. (2025). Exploring the use and usefulness of living guidelines for consumers: international online survey of patients' and carers' views. Journal of Clinical Epidemiology, 180, 111671. Scopus5 Europe PMC6 |
| 2025 | Whittle, S. L., Johnston, R. V., McDonald, S., Worthley, D., Campbell, T. M., Cyril, S., . . . Buchbinder, R. (2025). Stem cell injections for osteoarthritis of the knee. The Cochrane Database of Systematic Reviews, 4(4), CD013342-i-CD013342-362. Scopus5 WoS5 Europe PMC6 |
| 2024 | Yiu, Z. Z. N., McFarlane, E., & Whittle, S. L. (2024). ‘Live long and prosper’: living guidelines for immune-mediated inflammatory diseases. British Journal of Dermatology, 191(5), 647-649. |
| 2024 | Ramsay, H., Johnston, R. V., Cyril, S., Glennon, V., Grobler, L., Burgess, D. M., . . . Buchbinder, R. (2024). Dose reduction and discontinuation of biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) for people with psoriatic arthritis in remission or low disease activity. Cochrane Database of Systematic Reviews, 2024(12), CD015880. |
| 2024 | Tan, J., Renton, W. D., Whittle, S. L., Takken, T., Johnston, R. V., Tiller, G., . . . Buchbinder, R. (2024). Methotrexate for juvenile idiopathic arthritis. Cochrane Database of Systematic Reviews, 2024(2), CD003129-1-CD003129-67. Scopus7 WoS8 Europe PMC3 |
| 2024 | Mittinty, M. M., Mittinty, M. N., Buchbinder, R., Lassere, M., Chand, V., Whittle, S., . . . Hill, C. (2024). Interpersonal Process of Dyadic Coping in Rheumatoid Arthritis: A Perspective From the Australian Rheumatology Association Database. Journal of Rheumatology, 51(9), 862-869. Scopus2 WoS1 Europe PMC1 |
| 2024 | Pisaniello, H. L., Lester, S. E., Russell, O., Black, R., Tieu, J., Richards, B., . . . Whittle, S. L. (2024). The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD). Annals of the Rheumatic Diseases, 83(10), 1400-1402. |
| 2023 | Whittle, S. L., Glennon, V., & Buchbinder, R. (2023). Prioritization of clinical questions for the Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis. International Journal of Rheumatic Diseases, 26(12), 2410-2418. Scopus4 WoS5 Europe PMC9 |
| 2023 | Kamso, M. M., Pardo, J. P., Whittle, S. L., Buchbinder, R., Wells, G., Glennon, V., . . . Hazlewood, G. S. (2023). Crowd-sourcing and automation facilitated the identification and classification of randomized controlled trials in a living review. Journal of Clinical Epidemiology, 164, 1-8. Scopus3 WoS3 Europe PMC3 |
| 2023 | Ng, J. Q., Jafarov, T. H., Little, C. B., Wang, T., Ali, A. M., Ma, Y., . . . Mukherjee, S. (2023). Loss of Grem1-lineage chondrogenic progenitor cells causes osteoarthritis. Nature Communications, 14(1), 6909-1-6909-14. Scopus28 WoS27 Europe PMC26 |
| 2023 | Wang, H., Dewidar, O., Whittle, S. L., Ghogomu, E., Hazlewood, G., Leder, K., . . . Welch, V. (2023). Equity Considerations in COVID-19 Vaccination Studies of Individuals With Autoimmune Inflammatory Rheumatic Diseases. Arthritis Care and Research, 75(5), 967-974. |
| 2023 | Cheyne, S., Fraile Navarro, D., Hill, K., McDonald, S., Tunnicliffe, D., White, H., . . . Turner, T. (2023). Methods for living guidelines: early guidance based on practical experience. Paper 1: Introduction. Journal of Clinical Epidemiology, 155, 84-96. Scopus40 WoS43 Europe PMC34 |
| 2023 | Cheyne, S., Fraile Navarro, D., Buttery, A. K., Chakraborty, S., Crane, O., Hill, K., . . . Turner, T. (2023). Methods for living guidelines: early guidance based on practical experience. Paper 3: selecting and prioritizing questions for living guidelines. Journal of Clinical Epidemiology, 155, 73-83. Scopus21 WoS18 Europe PMC15 |
| 2023 | Synnot, A., Hill, K., Davey, J., English, K., Whittle, S. L., Buchbinder, R., . . . Turner, T. (2023). Methods for living guidelines: Early Guidance based on practical experience. Paper 2: Consumer engagement in living guidelines. Journal of Clinical Epidemiology, 155, 97-107. Scopus12 WoS13 Europe PMC12 |
| 2023 | Buchbinder, R., Glennon, V., Johnston, R. V., Brennan, S. E., Fong, C., Edward May, S., . . . Whittle, S. L. (2023). Australian recommendations on perioperative use of disease-modifying anti-rheumatic drugs in people with inflammatory arthritis undergoing elective surgery. Internal Medicine Journal, 53(7), 1248-1255. Scopus3 WoS3 Europe PMC2 |
| 2023 | Pisaniello, H. L., Lester, S., Russell, O., Black, R., Tieu, J., Richards, B., . . . Hill, C. L. (2023). Trajectories of self-reported pain-related health outcomes and longitudinal effects on medication use in rheumatoid arthritis: a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD). RMD Open, 9(3), e002962. Scopus7 WoS7 Europe PMC4 |
| 2023 | Lyon, A., Quinlivan, A., Lester, S., Barrett, C., Whittle, S. L., Rowett, D., . . . Hill, C. L. (2023). Vaccination Rates, Perceptions, and Information Sources Used by People With Inflammatory Arthritis. ACR Open Rheumatology, 5(2), 1-9. Scopus7 WoS5 Europe PMC5 |
| 2023 | Taylor, W. J., Willink, R., O'Connor, D. A., Patel, V., Bourne, A., Harris, I. A., . . . Buchbinder, R. (2023). Which clinical research questions are the most important? Development and preliminary validation of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network Research Question Importance Tool (ANZMUSC-RQIT).. PloS one, 18(3), e0281308. Scopus3 WoS2 Europe PMC3 |
| 2023 | Barrett, C., & Whittle, S. (2023). Philip Cameron Robinson, 1979-2023. Internal Medicine Journal, 53(3), 309-310. |
| 2023 | Sharma, C., Whittle, S., Haghighi, P. D., Burstein, F., & Keen, H. I. (2023). Response to Correspondence on Mining social media data to investigate patient perceptions regarding DMARD pharmacotherapy for rheumatoid arthritis'' by Reuter et al. Annals of the Rheumatic Diseases, 82(4), E92. |
| 2022 | Renton, W. D., Tiller, G., Munro, J., Tan, J., Johnston, R. V., Avery, J. C., . . . Buchbinder, R. (2022). Dose reduction and discontinuation of disease-modifying anti-rheumatic drugs (DMARDs) for juvenile idiopathic arthritis. Cochrane Database of Systematic Reviews, 2022(1), 1-17. Scopus2 |
| 2022 | Feterman Jimenez, D., Duron, G., Hendin, J., Mantovani Cardoso, E., Valenzuela-Almada, M. O., Vallejo, S., . . . Putman, M. S. (2022). Industry involvement in rheumatology consensus-based recommendations: a systematic review. Lancet Rheumatology, 4(2), e145-e152. |
| 2022 | Lalor, A. F., Brooker, J. E., Rozbroj, T., Whittle, S. L., Hill, C. L., Rowett, D., . . . O'Connor, D. A. (2022). Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies. Seminars in Arthritis and Rheumatism, 55(151988), 151988-1-151988-13. Scopus5 WoS6 Europe PMC5 |
| 2022 | Lee, C., Thomas, M., Ejaredar., Kassam, A., Whittle, S. L., Buchbinder, R., . . . Hazlewood, G. S. (2022). Crowdsourcing trainees in a living systematic review provided valuable experiential learning opportunities: A mixed-methods study. Journal of Clinical Epidemiology, 147, 142-150. Scopus6 WoS5 Europe PMC5 |
| 2022 | Khoo, T., Hill, C. L., Hoon, E., & Whittle, S. (2022). Patient Perspectives of Disease Activity, Medications and Substance Use in People with Fibromyalgia. Open Access Rheumatology: Research and Reviews, 14, 87-95. Scopus1 WoS1 Europe PMC1 |
| 2022 | Whittle, S. L., Glennon, V., Johnston, R. V., Avery, J. C., Bell, J. S., Brennan, S. E., . . . Buchbinder, R. (2022). Australian recommendations on tapering of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in inflammatory arthritis. Internal Medicine Journal, 52(10), 1799-1805. Scopus9 WoS7 Europe PMC8 |
| 2022 | Ponkilainen, V., Karjalainen, T. V., Kuitunen, I., Uimonen, M., Johnston, R. V., Saarinen, A., . . . Buchbinder, R. (2022). Perioperative use of disease modifying anti-rheumatic drugs (DMARDs) in people with inflammatory arthritis. Cochrane Database of Systematic Reviews, 2022(5). Scopus2 |
| 2022 | Quinlivan, A., Lester, S., Barrett, C., Whittle, S., Rowett, D., Black, R., . . . Hill, C. (2022). Attitudes of Australians with inflammatory arthritis to biologic therapy and biosimilars. Rheumatology Advances in Practice, 6(3), rkac099-1-rkac099-7. Scopus6 WoS6 Europe PMC6 |
| 2022 | Tsakas, J. J., Liew, D. F. L., Adams, C. L., Hill, C. L., Proudman, S., Whittle, S., . . . Robinson, P. C. (2022). Attitudes and practices in the laboratory monitoring of conventional synthetic disease modifying anti-rheumatic drugs by rheumatologists and rheumatology trainees. BMC Rheumatology, 6(1), 59-1-59-8. Scopus2 WoS2 Europe PMC1 |
| 2022 | Pisaniello, H. L., Whittle, S. L., Lester, S., Menz, F., Metcalf, R., McWilliams, L., . . . Proudman, S. (2022). Using the derived 28-joint disease activity score patient-reported components (DAS28-P) index as a discriminatory measure of response to disease-modifying anti-rheumatic drug therapy in early rheumatoid arthritis. BMC Rheumatology, 6(1), 11 pages. Scopus13 WoS13 Europe PMC12 |
| 2022 | Tiller, G., Renton, W. D., Tan, J., Whittle, S., Avery, J., Munro, J., & Buchbinder, R. (2022). Modified Delphi study to identify priority clinical questions for the Australian living guidelines for the management of Juvenile Idiopathic Arthritis.. Pediatric rheumatology online journal, 20(1), 52. Scopus2 WoS2 Europe PMC3 |
| 2022 | Khoo, T., Chin, A., & Whittle, S. (2022). Fibromyalgia: Small steps on a long journey. Medicine Today, 23(1-2), 43-48. |
| 2021 | Adams, L., Lester, S., Hoon, E., van der Haak, H., Proudman, C., Hall, C., . . . Hill, C. L. (2021). Patient satisfaction and acceptability with telehealth at specialist medical outpatient clinics during the COVID-19 pandemic in Australia.. Internal medicine journal, 51(7), 1028-1037. Scopus40 WoS39 Europe PMC36 |
| 2021 | Whittle, S. L., Hazlewood, G. S., Robinson, P., Johnston, R. V., Leder, K., Glennon, V., . . . Buchbinder, R. (2021). COVID-19 vaccination for people with autoimmune inflammatory rheumatic diseases on immunomodulatory therapies. Cochrane Database of Systematic Reviews, 2021(6), 16 pages. Scopus1 |
| 2021 | Glennon, V., Whittle, S. L., Hill, C. L., Johnston, R. V., Avery, J. C., Grobler, L., . . . Buchbinder, R. (2021). Short-term glucocorticoids for flares in people with rheumatoid arthritis receiving disease-modifying anti-rheumatic drugs (DMARDs). Cochrane Database of Systematic Reviews, 2021(11), 16 pages. Scopus5 |
| 2021 | Avery, J. C., Whittle, S. L., Johnston, R. V., Grobler, L., McKenzie, B. J., Cyril, S., . . . Buchbinder, R. (2021). Dose reduction and discontinuation of biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) in people with axial spondyloarthritis and low disease activity. Cochrane Database of Systematic Reviews, 2021(11), 16 pages. |
| 2021 | McKenzie, B. J., Whittle, S. L., Johnston, R. V., Hill, C. L., Pardo Pardo, J., Glennon, V., . . . Buchbinder, R. (2021). Long-term glucocorticoids for rheumatoid arthritis. Cochrane Database of Systematic Reviews, 2021(12), 17 pages. Scopus2 WoS1 |
| 2021 | Venter, G., Tieu, J., Black, R., Lester, S., Leonardo, N., Whittle, S. L., . . . Hill, C. L. (2021). PERSPECTIVES OF GLUCOCORTICOID USE IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS. ACR Open Rheumatology, 3(4), 231-238. Scopus13 WoS15 Europe PMC11 |
| 2021 | Ferreira, G. E., Zadro, J. R., O'Keeffe, M., Buchbinder, R., Maher, C., Latimer, J., . . . Clavisi, O. (2021). Challenges faced by musculoskeletal health research in Australia and New Zealand due to the COVID-19 pandemic. Internal Medicine Journal, 51(4), 622. Scopus1 |
| 2021 | Davis, C. R., Ruediger, C. D., Dyer, K. A., Lester, S., Graf, S. W., Kroon, F. P. B., . . . Hill, C. L. (2021). Colchicine is not effective for reducing osteoarthritic hand pain compared to placebo: a randomised, placebo-controlled trial (COLAH). Osteoarthritis and Cartilage, 29(2), 208-214. Scopus33 WoS28 Europe PMC23 |
| 2021 | Khadra, Y., Walker, J. G., Hakendorf, P., Proudman, S., Rischmueller, M., Hill, C. L., . . . Roberts-Thomson, P. J. (2021). Scleroderma renal crisis: observations from the South Australian Scleroderma Register. Internal Medicine Journal, 51(2), 235-242. Scopus4 WoS3 Europe PMC2 |
| 2020 | Sharma, C., Whittle, S., Haghighi, P. D., Burstein, F., Sa'adon, R., & Keen, H. (2020). Mining Social Media Data to Investigate Patient Perceptions Regarding DMARD Pharmacotherapy for Rheumatoid Arthritis. Annals of the Rheumatic Diseases, 79(11), 1432-1437. Scopus12 WoS12 Europe PMC11 |
| 2020 | Røe, Y., Buchbinder, R., Grotle, M., Whittle, S., Ramiro, S., Huang, H., . . . Østensjø, S. (2020). What do the OMERACT shoulder core set candidate instruments measure? An analysis using the refined international classification of functioning, disability, and health linking rules. Journal of Rheumatology, 47(10), 1557-1564. Scopus2 WoS3 Europe PMC2 |
| 2020 | Hazlewood, G. S., Whittle, S. L., Kamso, M. M., Akl, E. A., Wells, G. A., Tugwell, P., . . . Buchbinder, R. (2020). Disease-modifying anti-rheumatic drugs for rheumatoid arthritis: a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews, 2020(3). Scopus19 |
| 2020 | Putman, M. S., Sufka, P., Whittle, S., & Robinson, P. C. (2020). European consensus statements for interstitial lung disease in systemic sclerosis. Lancet Rheumatology, 2(6), e317-e318. Europe PMC1 |
| 2020 | Leonardo, N., Lester, S., Graham, M., Barett, C., Whittle, S., Rowett, D., . . . Hill, C. L. (2020). Selection and perception of methotrexate treatment information in people with rheumatoid arthritis. International Journal of Rheumatic Diseases, 23(6), 805-812. Scopus22 WoS21 Europe PMC18 |
| 2020 | Szeto, C. -C., Sugano, K., Wang, J. -G., Fujimoto, K., Whittle, S., Modi, G. K., . . . Chan, F. K. L. (2020). Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations.. Gut, 639(4), 617-629. Scopus110 WoS92 Europe PMC65 |
| 2020 | Buchbinder, R., Bourne, A., Latimer, J., Harris, I., Whittle, S., Richards, B., . . . ANZMUSC Clinical Trial Network. (2020). Early development of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network. Internal medicine journal, 50(1), 17-23. Scopus9 WoS8 Europe PMC11 |
| 2020 | Leonardo, N., Lester, S., Whittle, S., & Rischmueller, M. (2020). Review of gout clinic in a tertiary hospital setting.. Intern Med J, 50(1), 117-120. Scopus5 WoS4 Europe PMC4 |
| 2020 | Lowe, J. R., Briggs, A. M., Whittle, S., & Stephenson, M. D. (2020). A systematic review of the effects of probiotic administration in inflammatory arthritis. Complementary Therapies in Clinical Practice, 40, 101207-1-101207-13. Scopus24 WoS19 Europe PMC14 |
| 2020 | Sharma, C., Whittle, S., Haghighi, P. D., Burstein, F., & Keen, H. (2020). Sentiment analysis of social media posts on pharmacotherapy: A scoping review. Pharmacology Research and Perspectives, 8(5), 9 pages. Scopus16 WoS12 Europe PMC13 |
| 2020 | Buchbinder, R., Ramiro, S., Huang, H., Gagnier, J. J., Jia, Y., & Whittle, S. L. (2020). Measures of Adult Shoulder Function. Arthritis Care and Research, 72(S10), 250-293. Scopus18 WoS19 Europe PMC16 |
| 2019 | Wilsdon, T. D., Whittle, S. L., Thynne, T. R., & Mangoni, A. A. (2019). Methotrexate for psoriatic arthritis. Cochrane Database of Systematic Reviews, 2019(1), 111 pages. Scopus17 WoS49 Europe PMC29 |
| 2019 | Ramiro, S., Page, M. J., Whittle, S. L., Huang, H., Verhagen, A. P., Beaton, D. E., . . . Buchbinder, R. (2019). The OMERACT core domain set for clinical trials of shoulder disorders. The Journal of Rheumatology, 46(8), 969-975. Scopus35 WoS35 Europe PMC33 |
| 2019 | Tam, L. S., Wei, J. C. C., Aggarwal, A., Baek, H. J., Cheung, P. P., Chiowchanwisawakit, P., . . . Lau, C. S. (2019). 2018 APLAR axial spondyloarthritis treatment recommendations. International Journal of Rheumatic Diseases, 22(3), 340-356. Scopus60 WoS53 Europe PMC41 |
| 2019 | Page, M. J., O'Connor, D. A., Malek, M., Haas, R., Beaton, D., Huang, H., . . . OMERACT Shoulder Core Set Working Group. (2019). Patients' experience of shoulder disorders: a systematic review of qualitative studies for the OMERACT Shoulder Core Domain Set. Rheumatology, 58(8), 1410-1421. Scopus44 WoS46 Europe PMC42 |
| 2019 | Ying Chan, F. L., Lester, S., Whittle, S. L., & Hill, C. L. (2019). The utility of ESR, CRP and platelets in the diagnosis of GCA. BMC Rheumatology, 3(1), 7 pages. Scopus48 WoS41 Europe PMC36 |
| 2019 | Whittle, S. L., Johnston, R. V., McDonald, S., Worthley, D., Campbell, T. M., & Buchbinder, R. (2019). Stem cell injections for osteoarthritis of the knee. Cochrane Database of Systematic Reviews, 2019(5). Scopus11 |
| 2019 | Whittle, S. L., Johnston, R. V., McDonald, S., Paterson, K. L., & Buchbinder, R. (2019). Autologous blood product injections including platelet-rich plasma for osteoarthritis of the knee. Cochrane Database of Systematic Reviews, 2019(5). Scopus5 |
| 2019 | Cai, K., Whittle, S. L., Richards, B. L., Ramiro, S., Falzon, L., & Buchbinder, R. (2019). Marine oil supplements for rheumatoid arthritis. Cochrane Database of Systematic Reviews, 2019(12). Scopus1 |
| 2018 | Wilsdon, T., Thynne, T., Mangoni, A., & Whittle, S. (2018). METHOTREXATE FOR PSORIATIC ARTHRITIS. INTERNAL MEDICINE JOURNAL, 48, 14. |
| 2018 | Bourne, A. M., Johnston, R. V., Cyril, S., Briggs, A. M., Clavisi, O., Duque, G., . . . Buchbinder, R. (2018). Scoping review of priority setting of research topics for musculoskeletal conditions. BMJ Open, 8(12), e023962-1-e023962-9. Scopus37 WoS37 Europe PMC35 |
| 2018 | Pisaniello, H., Lester, S., Gonzalez-Chica, D., Stocks, N., Longo, M., Sharplin, G., . . . Hill, C. (2018). Gout prevalence and predictors of urate-lowering therapy use: Results from a population-based study. Arthritis Research and Therapy, 20(1), 10 pages. Scopus44 WoS40 Europe PMC25 |
| 2018 | Chua, A. C. L., Venkataraman, K., & Whittle, S. L. (2018). Occipital condyle syndrome mimicking giant cell arteritis as the first manifestation of disseminated malignancy. Internal Medicine Journal, 48(9), 1163-1164. Scopus2 WoS1 |
| 2018 | Lowe, J., Briggs, A., Whittle, S., Hoon, E., & Stephenson, M. (2018). Effectiveness of probiotics in the management of inflammatory arthritis: a systematic review protocol. JBI Database of Systematic Reviews and Implementation Report, 16(12), 2295-2303. Scopus6 Europe PMC3 |
| 2017 | Wilsdon, T. D., Whittle, S. L., Thynne, T. R. J., & Mangoni, A. A. (2017). Methotrexate for psoriatic arthritis. Cochrane Database of Systematic Reviews, 2017(7). Scopus40 |
| 2017 | Black, R., Lester, S., Buchbinder, R., Barrett, C., Lassere, M., March, L., . . . Hill, C. (2017). Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry. Arthritis Research and Therapy, 19(1), 253-1-253-8. Scopus38 WoS38 Europe PMC30 |
| 2017 | Truong, S. L., Saad, N. F., Robinson, P. C., Cowderoy, G., Lim, I., Schachna, L., . . . Brown, M. A. (2017). Consensus statements on the imaging of axial spondyloarthritis in Australia and New Zealand. Journal of Medical Imaging and Radiation Oncology, 61(1), 58-69. Scopus9 WoS9 Europe PMC6 |
| 2017 | Haghighi, P. D., Kang, Y. B., Buchbinder, R., Burstein, F., & Whittle, S. (2017). Investigating subjective experience and the influence of weather among individuals with fibromyalgia: A content analysis of Twitter. Jmir Public Health and Surveillance, 3(1), e4. Scopus18 Europe PMC11 |
| 2017 | Goldacre, B., Whittle, S., Ernst, E., & Mendel, J. (2017). Authors' reply to Beales. BMJ Online, 356, 1 page. |
| 2016 | Pisaniello, H. L., & Whittle, S. (2016). Fibromyalgia: Finding the silver lining around a common chronic pain disorder. Medicine Today, 17(12), 54-56. |
| 2016 | Milman, N., Whittle, S., Hill, C., El Sayad, J., & Wells, G. (2016). Methotrexate for polymyalgia rheumatica. Cochrane Database of Systematic Reviews, 2016(5), 9 pages. |
| 2016 | Milman, N., Hill, C., Whittle, S., El Sayad, J., & Wells, G. (2016). Methotrexate for giant cell arteritis. Cochrane Database of Systematic Reviews, 2016(5), 9 pages. Scopus1 |
| 2016 | Tieu, J., Lester, S., Whittle, S., Peh, C. A., Goldblatt, F., Proudman, S., . . . Hill, C. (2016). RITUXIMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS: A REVIEW OF USE IN SOUTH AUSTRALIA. INTERNAL MEDICINE JOURNAL, 46, 35. |
| 2016 | Bird, P., Shnier, R., Taylor, A., White, C., Whittle, S., Basic, N., . . . Tesla, P. (2016). EFFECT OF CALIBRATION AND TRAINING ON MAGNETIC RESONANCE IMAGING SACROILIITIS SCORING AND SI JOINT RADIOGRAPHIC SCORING AGREEMENT. INTERNAL MEDICINE JOURNAL, 46, 38. |
| 2016 | Mendel, J., Goldacre, B., Ernst, E., & Whittle, S. (2016). Problems with ethical approval and how to fix them: Lessons from three trials in rheumatoid arthritis. BMJ (Online), 354, 1-4. Scopus7 WoS6 Europe PMC3 |
| 2015 | Ting, K., Graf, S. W., & Whittle, S. L. (2015). Update on the diagnosis and management of gout. MEDICAL JOURNAL OF AUSTRALIA, 203(2), 86-+. WoS3 |
| 2015 | Whittle, S., & Buchbinder, R. (2015). Rotator Cuff Disease. ANNALS OF INTERNAL MEDICINE, 162(1), ITC1-ITC16. WoS66 |
| 2015 | Ting, K., Hill, C., & Whittle, S. (2015). Quality of reporting of interventional animal studies in rheumatology: a systematic review using the ARRIVE guidelines. International Journal of Rheumatic Diseases, 18(5), 488-494. Scopus35 WoS37 Europe PMC29 |
| 2015 | Ting, K., Graf, S. W., & Whittle, S. L. (2015). Update on the diagnosis and management of gout. Medical Journal of Australia, 203(2), 86-88. Scopus5 WoS1 Europe PMC3 |
| 2015 | Whittle, S., & Buchbinder, R. (2015). Rotator cuff disease. Annals of Internal Medicine, 162(1), ITC1-ITC15. Scopus81 WoS1 Europe PMC66 |
| 2015 | Graf, S., Whittle, S., Wechalekar, M., Moi, J., Barrett, C., Hill, C., . . . Zochling, J. (2015). Australian and New Zealand recommendations for the diagnosis and management of gout: Integrating systematic literature review and expert opinion in the 3e Initiative. International Journal of Rheumatic Diseases, 18(3), 341-351. Scopus53 WoS37 Europe PMC34 |
| 2014 | Graf, S. W., & Whittle, S. L. (2014). Isotretinoin-induced skeletal hyperostosis. SpringerPlus, 3(1), 698-1-698-4. Scopus7 WoS7 Europe PMC6 |
| 2014 | Moghaddami, M., James, M., Whittle, S., & Cleland, L. (2014). Synovial fluid myeloid dendritic cells display important differences compared to monocyte-derived dendritic cells prepared in vitro. Clinical & Translational Immunology, 3(8), e23-1-e23-7. Scopus1 WoS1 |
| 2014 | Richards, B. L., Whittle, S., Buchbinder, R., Barrett, C., Lynch, N., Major, G., . . . Zochling, J. (2014). Australian and New Zealand evidence-based recommendations for pain management by pharmacotherapy in adult patients with inflammatory arthritis. International Journal of Rheumatic Diseases, 17(7), 738-748. Scopus3 WoS2 Europe PMC2 |
| 2014 | Robinson, P., Bird, P., Lim, I., Saad, N., Schachna, L., Taylor, A., . . . Brown, M. (2014). Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA). International Journal of Rheumatic Diseases, 17(5), 548-556. Scopus12 WoS10 Europe PMC8 |
| 2014 | Bourne, A. M., Whittle, S. L., Richards, B. L., Maher, C. G., & Buchbinder, R. (2014). The scope, funding and publication of musculoskeletal clinical trials performed in Australia. Medical Journal of Australia, 200(2), 88-91. Scopus22 WoS21 Europe PMC17 |
| 2013 | Graf, S., Buchbinder, R., Zochling, J., & Whittle, S. (2013). The accuracy of methods for urate crystal detection in synovial fluid and the effect of sample handling: A systematic review. Clinical Rheumatology, 32(2), 225-232. Scopus32 WoS23 Europe PMC18 |
| 2013 | Whittle, S., Richards, B., & Buchbinder, R. (2013). Opioid analgesics for rheumatoid arthritis pain. JAMA: Journal of the American Medical Association, 309(5), 485-486. Scopus26 WoS24 Europe PMC20 |
| 2012 | Wechalekar, M., Lester, S., Proudman, S., Cleland, L., Whittle, S., Rischmueller, M., & Hill, C. (2012). Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement. Arthritis and Rheumatism, 64(5), 1316-1322. Scopus51 WoS49 Europe PMC40 |
| 2012 | Whittle, S., Colebatch, A., Buchbinder, R., Edwards, C., Adams, K., Englbrecht, M., . . . van der Heijde, D. (2012). Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e initiative. Rheumatology, 51(8), 1416-1425. Scopus83 WoS58 Europe PMC43 |
| 2012 | Whittle, S. L., Richards, B. L., van der Heijde, D. M., & Buchbinder, R. (2012). The efficacy and safety of opioids in inflammatory arthritis: a cochrane systematic review. The Journal of Rheumatology, 39(Suppl. 90), 40-46. Scopus18 WoS19 Europe PMC16 |
| 2012 | Richards, B. L., Whittle, S. L., van der Heijde, D. M., & Buchbinder, R. (2012). The efficacy and safety of muscle relaxants in inflammatory arthritis: a Cochrane systematic review. The Journal of Rheumatology, Suppl. 90(SUPPL. 90), 34-39. Scopus15 WoS11 Europe PMC7 |
| 2012 | Richards, B. L., Whittle, S. L., van der Heijde, D. M., & Buchbinder, R. (2012). The efficacy and safety of antidepressants in inflammatory arthritis: a Cochrane systematic review. Journal of Rheumatology, 39(90), 21-27. Scopus23 WoS15 Europe PMC11 |
| 2012 | Richards, B. L., Whittle, S. L., van der Heijde, D. M., & Buchbinder, R. (2012). Efficacy and safety of neuromodulators in inflammatory arthritis: a Cochrane systematic review. Journal of Rheumatology, 39(Suppl. 90), 28-33. Scopus10 WoS7 Europe PMC4 |
| 2012 | Richards, B., Whittle, S., & Buchbinder, R. (2012). Neuromodulators for pain management in rheumatoid arthritis. Cochrane Database of Systematic Reviews, 1(1), 1-51. Scopus82 WoS67 Europe PMC46 |
| 2012 | Richards, B., Whittle, S., & Buchbinder, R. (2012). Muscle relaxants for pain management in rheumatoid arthritis. Cochrane Database of Systematic Reviews, 2012(1), CD008922-1-CD008922-38. Scopus72 WoS30 Europe PMC27 |
| 2012 | Leah, E. (2012). Rheumatoid arthritis: Putting feet forward in disease assessment.. Nature reviews. Rheumatology, 8(2), 64. |
| 2011 | Richards, B. L., Whittle, S. L., & Buchbinder, R. (2011). Antidepressants for pain management in rheumatoid arthritis. Cochrane Database of Systematic Reviews (Online), 11(11), 1-67. Scopus60 WoS39 Europe PMC38 |
| 2011 | Whittle, S. L., Richards, B. L., Husni, E., & Buchbinder, R. (2011). Opioid therapy for treating rheumatoid arthritis pain. Cochrane database of systematic reviews (Online), (11), 1-60. Scopus105 WoS84 Europe PMC54 |
| 2010 | Katikireddi, V., Whittle, S., & Hill, C. (2010). Tumour necrosis factor inhibitors and risk of serious infection in rheumatoid arthritis. International Journal of Rheumatic Diseases, 13(1), 12-26. Scopus22 WoS19 Europe PMC15 |
| 2010 | Wechalekar, M. D., Rischmueller, M., Whittle, S., Burnet, S., & Hill, C. L. (2010). Prolonged remission of chronic reactive arthritis treated with three infusions of infliximab. Journal of Clinical Rheumatology, 16(2), 79-80. Scopus20 WoS15 Europe PMC13 |
| 2009 | Hill, C. L., Cole, A., Lester, S., & Whittle, S. L. (2009). Steroid sparing drug treatments for giant cell arteritis. Cochrane Database of Systematic Reviews, (1). Scopus2 |
| 2009 | Whittle, S. L., Cole, A., Lester, S., & Hill, C. L. (2009). Steroid sparing drug treatments for polymyalgia rheumatica. Cochrane Database of Systematic Reviews, (1). |
| 2008 | Mangat, P., Whittle, S., Cleland, L., & Limaye, S. (2008). Digital vasculitis: a late complication of anti-tumour necrosis factor alpha therapy. Clinical Rheumatology, 27(12), 1593-1595. Scopus3 WoS3 Europe PMC2 |
| 2004 | Whittle, S. L., & Hughes, R. A. (2004). Folate supplementation and methotrexate treatment in rheumatoid arthritis: A review. Rheumatology, 43(3), 267-271. Scopus235 WoS188 Europe PMC147 |
| 2004 | Bamji, A., Whittle, S., & Hughes, R. A. (2004). Methotrexate and folic: What is the optimal combination? (multiple letters) [7]. Rheumatology, 43(8), 1060-1061. Scopus1 Europe PMC1 |
| 2004 | Whittle, S., & Hughes, R. A. (2004). Methotrexate and folic acid: what is the optimal combination? Reply. RHEUMATOLOGY, 43(8), 1061. |
| 2002 | Whittle, S., James, M., & Cleland, L. G. (2002). Focus on meloxicam. Medicine Today, 3(9), 73-76. |
| 1996 | Edwards, D. J., Whittle, S. L., Nissen, M. J., Cohen, B., Oakeshott, R. D., & Keene, G. C. R. (1996). Radiographic changes in the knee after meniscal transplantation - An experimental study in a sheep model. AMERICAN JOURNAL OF SPORTS MEDICINE, 24(2), 222-226. WoS28 Europe PMC21 |
| - | Mittinty, M. M., Mittinty, M., Buchbinder, R., Lassere, M., Chand, V., Whittle, S., . . . Hill, C. (n.d.). Dyadic Coping with Rheumatoid Arthritis: A Couple Perspective from the Australian Rheumatology Association Database Registry. SSRN Electronic Journal. |
| Year | Citation |
|---|---|
| 2024 | Terrett, A., Chin, A., Kwon, M., Whittle, S., & Hill, C. (2024). Recommendations for the Perioperative Use of DMARDs in Rheumatic Diseases: A Scoping Review. In ARTHRITIS & RHEUMATOLOGY Vol. 76 (pp. 2123-2124). WILEY. |
| 2024 | Hill, C., Kwon, M., Chin, A., Lester, S., & Whittle, S. (2024). DMARD MONITORING IN RHEUMATOID ARTHRITIS: A SCOPING REVIEW OF INTERNATIONAL/NATIONAL GUIDELINES. In ANNALS OF THE RHEUMATIC DISEASES Vol. 83 (pp. 2 pages). AUSTRIA, Vienna: ELSEVIER. DOI |
| 2023 | Crouch, B., Kwiatek, R., True, B., Whittle, S., Wall, A., & Sherwood, V. (2023). DIFFUSION TENSOR IMAGING IN FIBROMYALGIA SYNDROME-A PILOT STUDY. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 32-33). WILEY. |
| 2023 | Kwiatek, R., & Whittle, S. (2023). MEMANTINE-A USEFUL BUT FORGOTTEN PAIN MODULATOR IN FIBROMYALGIA MANAGEMENT? A CLINICAL AUDIT. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 33). WILEY. |
| 2023 | Schwetlik, S., Wigg, A., Tieu, J., Lyne, S., Whittle, S., Proudman, S., & Hill, C. (2023). THE VALUE OF AN ADVANCED PRACTICE PHYSIOTHERAPIST-LED NEW PATIENT RHEUMATOLOGY SERVICE: A CLINICAL AUDIT OF THE MUSCULOSKELETAL ASSESSMENT CLINIC AT THE QUEEN ELIZABETH HOSPITAL. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 17-18). WILEY. |
| 2023 | Sukkar, M., Keen, H., March, L., Proudman, S., Bradbury, L., Hardy, L., . . . Hill, C. (2023). DEVELOPING QUALITY STANDARDS FOR THE DIAGNOSIS AND MANAGEMENT OF RHEUMATOID ARTHRITIS IN AUSTRALIA. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 52). WILEY. |
| 2023 | Pisaniello, H. L., Lester, S., Russell, O., Black, R., Tieu, J., Richards, B., . . . Whittle, S. (2023). POORER PAIN-RELATED HEALTH STATUS IN PATIENTS WITH RHEUMATOID ARTHRITIS CORRELATES WITH AN INCREASE IN HOSPITALISATIONS AND MORTALITY: A PROSPECTIVE COHORT ANALYSIS USING THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 22). WILEY. |
| 2023 | Pisaniello, H. L., Lester, S., Russell, O., Black, R., Tieu, J., Richards, B., . . . Hill, C. (2023). TRAJECTORIES OF SELF-REPORTED PAIN-RELATED HEALTH OUTCOMES AND THE ASSOCIATION WITH SOCIODEMOGRAPHIC FACTORS AND MEDICATION USE IN RHEUMATOID ARTHRITIS: A PROSPECTIVE COHORT ANALYSIS USING THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 21-22). WILEY. |
| 2023 | Dartnell, J., Brown, S., Barrett, C., Hardy, L., Buchbinder, R., Whittle, S., . . . Hill, C. (2023). COLLECTIVE IMPACT APPROACH FOR MORE EFFECTIVE KNOWLEDGE TRANSLATION. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 53). WILEY. |
| 2023 | Lovato, N., Reynolds, A., Whittle, S., Watson, N., Dyer, K., Gill, T., . . . Hill, C. (2023). DEFINING CLINICAL SLEEP DISORDERS IN FIBROMYALGIA: ROLE FOR UNIVERSAL SCREENING?. In INTERNAL MEDICINE JOURNAL Vol. 53 (pp. 41). WILEY. |
| 2022 | Khoo, T., Lester, S., Hill, C., Whittle, S., Black, R., Tieu, J., & Rischmueller, M. (2022). CONNECTIVE TISSUE DISEASE RELATED INTERSTITIAL LUNG DISEASE IN A RHEUMATOLOGY CLINIC POPULATION. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 35). WILEY. |
| 2022 | Russell, O., Khoo, T., Hill, C., Whittle, S., Tieu, J., Lyne, S., & Burnet, S. (2022). AN EXPERIENCE OF THE FIRST PUBLIC RURAL RHEUMATOLOGY CLINIC IN SOUTH AUSTRALIA (SA). In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 35). WILEY. |
| 2022 | Ye, M. J., Sinnathurai, P., Hill, C., Barrett, C., Hardy, L., Buchbinder, R., . . . Quyen, D. (2022). ENGAGING CLINICIANS AND CONSUMERS IN THE DESIGN AND IMPLEMENTATION OF A NATIONAL EDUCATION PROGRAM FOR INFLAMMATORY ARTHRITIS. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 31). WILEY. |
| 2021 | Khoo, T., Hill, C., Hoon, E., & Whittle, S. (2021). MEDICATION USE, COMORBIDITIES AND DISEASE ACTIVITY OF PATIENTS WITH FIBROMYALGIA IN A HOSPITAL OUTPATIENT CLINIC. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 48). WILEY. |
| 2021 | Lyon, A., Quinlivan, A., Lester, S., Barrett, C., Whittle, S., Marine, F., . . . Hill, C. (2021). VACCINATION RATES, PERCEPTIONS AND INFORMATION SOURCES UTILISED BY AUSTRALIAN PATIENTS WITH INFLAMMATORY ARTHRITIS. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 15). WILEY. |
| 2021 | Sheppard, J., Dartnell, J., Granger, R., Sinnathurai, P., Buchbinder, R., Hill, C., . . . Hayward, K. (2021). INITIATING A NATIONAL CONSORTIUM APPROACH TO SUPPORT OPTIMAL USE OF bDMARDs. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 22-23). WILEY. |
| 2021 | Kwiatek, R., Crouch, B., True, B., Whittle, S., Walls, A., & Sherwood, V. (2021). NEUROINFLAMMATION IN PRECUNEUS AND ISOLATED ELEVATED CHOLINE IN MEDIAL PREFRONTAL CORTEX CONFIRMED IN FIBROMYALGIA SYNDROME. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 43-44). WILEY. |
| 2021 | Johnson, J., Lynch, L., Gordon, M., Whittle, S., & Hill, C. (2021). EXPLORING OPIOID USE IN THE CONTEXT OF RHEUMATOLOGY DISEASE IN AN OUTPATIENT SETTING. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 24-25). WILEY. |
| 2021 | Danicic, J., Jung, M., Stamp, L., Dalbeth, N., & Whittle, S. (2021). STEM CELL THERAPY FOR MUSCULOSKELETAL DISEASES: A RAPID REVIEW. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 35). WILEY. |
| 2021 | Lian, A., Keen, H., Whittle, S., & Sharma, C. (2021). A COMPARISON BETWEEN RHEUMATOID ARTHRITIS PAIN DESCRIPTORS IN UNPROMPTED FREE TEXT FROM THE INTERNET AND THE MacGill PAIN QUESTIONNAIRE. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 48). WILEY. |
| 2021 | Tiller, G., Renton, W., Munro, J., Whittle, S., Avery, J., Johnston, R., & Buchbinder, R. (2021). APRG MEMBER SURVEY TO IDENTIFY PRIORITY QUESTIONS FOR A LIVING GUIDELINE FOR THE PHARMACOLOGICAL MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS. In INTERNAL MEDICINE JOURNAL Vol. 51 (pp. 36). WILEY. |
| 2020 | Jimenez, D. F., Duron, G., Duarte-Garcia, A., Sufka, P., Whittle, S., Robinson, P., . . . Putman, M. (2020). A Systematic Review to Quantify the Extent of Pharmaceutical Company Involvement in Rheumatology Consensus-Based Recommendations. In ARTHRITIS & RHEUMATOLOGY Vol. 72 (pp. 4 pages). ELECTR NETWORK: WILEY. |
| 2020 | Kwiatek, R., Crouch, B., True, B., Whittle, S., Walls, A., & Sherwood, V. (2020). NEUROINFLAMMATION IN FIBROMYALGIA ASSESSED BY PROTON MAGNETIC RESONANCE SPECTROSCOPY - A PILOT STUDY. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 48-49). WILEY. |
| 2020 | Davis, C., Ruediger, C., Dyer, K., Lester, S., Graf, S., Kroon, F. P. B., . . . Hill, C. (2020). COLCHICINE IS NOT EFFECTIVE FOR REDUCING OSTEOARTHRITIC HAND PAIN COMPARED TO PLACEBO: A RANDOMISED, PLACEBO-CONTROLLED TRIAL (COLAH). In ANNALS OF THE RHEUMATIC DISEASES Vol. 79 (pp. 793-794). ELECTR NETWORK: ELSEVIER. DOI WoS2 |
| 2020 | Dartnell, J., Elliott, J., Buchbinder, R., Hill, C., Barrett, C., Marine, F., . . . de Wever, J. (2020). DEVELOPING A COLLABORATIVE NATIONAL PROGRAM TO OPTIMISE USE OF BDMARDS. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 40-41). WILEY. |
| 2020 | Whittle, S., & Buchbinder, R. (2020). DURABILITY OF RHEUMATOLOGY GUIDELINE RECOMMENDATIONS: AN ANALYSIS OF UPDATED EULAR GUIDELINES 2005-2019. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 41). WILEY. |
| 2020 | Whittle, S., Thomas, M., Kamso, M. M., Pardo, J. P., Buchbinder, R., & Hazlewood, G. (2020). A LIVING NETWORK META-ANALYSIS OF TREATMENTS FOR RHEUMATOID ARTHRITIS: NOVELTY AT THE FRONTIER OF LIVING EVIDENCE. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 39). WILEY. |
| 2019 | Sharma, C., Whittle, S., Haghighi, P. D., Burstein, F., Sa'adon, R., & Keen, H. (2019). Mining Social Media Data to Investigate Patient Perceptions Regarding DMARD Pharmacotherapy for Rheumatoid Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 71 (pp. 2 pages). GA, Atlanta: WILEY. |
| 2018 | Calderon, L., Whittle, S., Hill, C., Sayad, J., Wells, G., & Milman, N. (2018). Methotrexate for Polymyalgia Rheumatica. In JOURNAL OF RHEUMATOLOGY Vol. 45 (pp. 1025-1026). Vancouver, CANADA: J RHEUMATOL PUBL CO. |
| 2018 | Leonardo, N., Lester, S., Graham, M., Whittle, S., Rowett, D., Buchbinder, R., & Hill, C. (2018). Attitudes and Beliefs Regarding Methotrexate in Patients with Rheumatoid Arthritis: Results from Australian Rheumatology Association Database. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 2 pages). IL, Chicago: WILEY. WoS1 |
| 2013 | Merriman, T., Phipps-Green, A., Black, M., Cadzow, M., Merriman, M., Topless, R., . . . Batt, C. (2013). SUGAR-SWEETENED BEVERAGE CONSUMPTION: A RISK FACTOR FOR PREVALENT GOUT THAT INTERACTS WITH SLC2A9 GENOTYPE IN A NON-ADDITIVE FASHION. In INTERNAL MEDICINE JOURNAL Vol. 43 (pp. 2). WILEY-BLACKWELL. |
| 2003 | Whittle, S., Lester, S. E., Downie-Doyle, S., Pile, K. D., & Rischmueller, M. (2003). Estrogen receptor alpha IVS1-401 (T/C) polymorphism in primary Sjogren's syndrome.. In ARTHRITIS AND RHEUMATISM Vol. 48 (pp. S567). ORLANDO, FLORIDA: WILEY-LISS. |
| Year | Citation |
|---|---|
| 2021 | Quinlivan, A., Lester, S., Barrett, C., Whittle, S., Rowett, D., Black, R., . . . Hill, C. (2021). ATTITUDES OF AUSTRALIANS WITH INFLAMMATORY ARTHRITIS TO BIOLOGIC THERAPY AND BIOSIMILARS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2020 | Venter, G., Tieu, J., Black, R., Lester, S., Leonardo, N., Whittle, S. L., . . . Hill, C. L. (2020). PERSPECTIVES OF GLUCOCORTICOID USE IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2020 | Davis, C., Ruediger, C., Dyer, K., Lester, S., Graf, S., Kroon, F., . . . Hill, C. (2020). COLCHICINE IS NOT EFFECTIVE FOR REDUCING OSTEOARTHRITIC HAND PAIN COMPARED TO PLACEBO: A RANDOMISED, PLACEBO-CONTROLLED TRIAL (COLAH). Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. WoS1 |
| 2020 | Whittle, S., Hill, C., & Buchbinder, R. (2020). ARA MEMBER SURVEY TO IDENTIFY PRIORITY QUESTIONS FOR A LIVING GUIDELINE FOR THE PHARMACOLOGICAL MANAGEMENT OF RHEUMATOID ARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. WoS2 |
| 2020 | Khoo, T., Hill, C., & Whittle, S. (2020). MEDICATION USE AND COMORBIDITIES OF PATIENTS WITH FIBROMYALGIA IN A HOSPITAL OUTPATIENT CLINIC. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2020 | Lalor, A. F., Brooker, J. E., Rozbroj, T., Whittle, S., Hill, C., Rowett, D., . . . Buchbinder, R. (2020). CLINICIAN PERSPECTIVES FACTORS INFLUENCING PRESCRIBING AND USE OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN INFLAMMATORY RHEUMATIC DISORDERS FROM THE PERSPECTIVES OF CLINICIANS: A QUALITATIVE EVIDENCE SYNTHESIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2020 | Lee, C., Thomas, M., Whittle, S., Buchbinder, R., Kamso, M., Pardo, J., & Hazlewood, G. (2020). Development and Pilot of Novel Process Using Machine Learning and Crowd-Sourcing to Conduct a Living Systematic Review of Rheumatoid Arthritis Drug Therapy. Poster session presented at the meeting of JOURNAL OF RHEUMATOLOGY. Victoria, CANADA: J RHEUMATOL PUBL CO. |
| 2019 | Calderon, L., Milman, N., Hill, C., Whittle, S., Sayad, J., Wells, G., & Pardo, J. (2019). Methotrexate for Giant Cell Arteritis. Poster session presented at the meeting of JOURNAL OF RHEUMATOLOGY. Montreal, CANADA: J RHEUMATOL PUBL CO. |
| 2018 | Leonardo, N., Lester, S., Graham, M., Whittle, S., Rowett, D., Buchbinder, R., & Hill, C. (2018). ATTITUDES OF RHEUMATOID ARTHRITIS PATIENTS TO METHOTREXATE. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2018 | Chan, F., Lester, S., Whittle, S., & Hill, C. (2018). THE UTILITY OF ESR, CRP AND PLATELETS IN THE DIAGNOSIS OF GCA: A SOUTH AUSTRALIAN STATEWIDE ANALYSIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2017 | Whittle, S., Menz, F., Lester, S., Proudman, S., & Hill, C. (2017). THE DAS28-P INDEX AS A PREDICTOR OF POOR SUBJECTIVE RESPONSE TO DMARD THERAPY IN EARLY RHEUMATOID ARTHRITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. WoS1 |
| 2017 | Black, R., Lester, S., Buchbinder, R., Barrett, C., Lassere, M., March, L., . . . Hill, C. (2017). FACTORS ASSOCIATED WITH ORAL GLUCOCORTICOID USE IN PATIENTS WITH RHEUMATOID ARTHRITIS ENROLLED IN THE AUSTRALIAN RHEUMATOLOGY ASSOCIATION DATABASE (ARAD). Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2017 | Pisaniello, H., Lester, S., Gonzalez-Chica, D., Longo, M., Sharplin, G., Dal Grande, E., . . . Hill, C. (2017). PREVALENCE AND PREDICTORS OF GOUT AND ALLOPURINOL USE, AND THEIR ASSOCIATION WITH RISK PERCEPTION: RESULTS FROM A SOUTH AUSTRALIAN POPULATION-BASED STUDY. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. WoS1 |
| 2015 | Ting, K., Whittle, S., & Hill, C. (2015). QUALITY OF REPORTING OF INTERVENTIONAL ANIMAL STUDIES IN RHEUMATOLOGY. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2015 | Haghighi, P. D., Kang, Y. -B., Tuan, H., Buchbinder, R., Burstein, F., & Whittle, S. (2015). Investigation of Environmental Associations of Fibromyalgia Pain Using Twitter Content Analysis. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Francisco: WILEY. |
| 2013 | Bourne, A., Whittle, S., Richards, B., Maher, C., & Buchbinder, R. (2013). MUSCULOSKELETAL CLINICAL TRIALS IN AUSTRALIA: WHAT TRIALS ARE BEING PERFORMED, WHO IS FUNDING THEM AND WHERE ARE THEY BEING PUBLISHED?. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2011 | Richards, B., Whittle, S., & Buchbinder, R. (2011). THE EFFICACY AND SAFETY OF MUSCLE RELAXANTS IN INFLAMMATORY ARTHRITIS: A COCHRANE SYSTEMATIC LITERATURE REVIEW. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2011 | Richards, B., Whittle, S., & Buchbinder, R. (2011). THE EFFICACY AND SAFETY OF NEUROMODULATORS IN INFLAMMATORY ARTHRITIS: A COCHRANE SYSTEMATIC REVIEW. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2011 | Richards, B., Whittle, S., & Buchbinder, R. (2011). THE EFFICACY AND SAFETY OF ANTI-DEPRESSANTS IN INFLAMMATORY ARTHRITIS: A COCHRANE SYSTEMATIC REVIEW. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2011 | Whittle, S., Richards, B., & Buchbinder, R. (2011). THE EFFICACY AND SAFETY OF OPIOIDS IN RHEUMATOID ARTHRITIS: A COCHRANE SYSTEMATIC REVIEW. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| Date | Role | Board name | Institution name | Country |
|---|---|---|---|---|
| 2016 - 2018 | Treasurer | Australian Rheumatology Association | Australian Rheumatology Association | Australia |
Connect With Me
External Profiles
